Viewing Study NCT00334750


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2026-01-25 @ 3:24 AM
Study NCT ID: NCT00334750
Status: COMPLETED
Last Update Posted: 2021-02-02
First Post: 2006-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glaucoma, Open-Angle View
None Ocular Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Glaucoma, Open-Angle Ocular Hypertension Risk factors Canadian View